1. Home
  2. THAR vs SGBX Comparison

THAR vs SGBX Comparison

Compare THAR & SGBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THAR
  • SGBX
  • Stock Information
  • Founded
  • THAR 2017
  • SGBX 2007
  • Country
  • THAR United States
  • SGBX United States
  • Employees
  • THAR N/A
  • SGBX N/A
  • Industry
  • THAR Biotechnology: Pharmaceutical Preparations
  • SGBX RETAIL: Building Materials
  • Sector
  • THAR Health Care
  • SGBX Consumer Discretionary
  • Exchange
  • THAR Nasdaq
  • SGBX Nasdaq
  • Market Cap
  • THAR 3.3M
  • SGBX 2.7M
  • IPO Year
  • THAR 2022
  • SGBX 2017
  • Fundamental
  • Price
  • THAR $1.82
  • SGBX $0.65
  • Analyst Decision
  • THAR Strong Buy
  • SGBX
  • Analyst Count
  • THAR 1
  • SGBX 0
  • Target Price
  • THAR $17.00
  • SGBX N/A
  • AVG Volume (30 Days)
  • THAR 41.7K
  • SGBX 1.6M
  • Earning Date
  • THAR 08-08-2025
  • SGBX 06-13-2025
  • Dividend Yield
  • THAR N/A
  • SGBX N/A
  • EPS Growth
  • THAR N/A
  • SGBX N/A
  • EPS
  • THAR N/A
  • SGBX N/A
  • Revenue
  • THAR N/A
  • SGBX $4,574,857.00
  • Revenue This Year
  • THAR N/A
  • SGBX $1,628.82
  • Revenue Next Year
  • THAR N/A
  • SGBX N/A
  • P/E Ratio
  • THAR N/A
  • SGBX N/A
  • Revenue Growth
  • THAR N/A
  • SGBX N/A
  • 52 Week Low
  • THAR $0.95
  • SGBX $0.30
  • 52 Week High
  • THAR $6.39
  • SGBX $3.75
  • Technical
  • Relative Strength Index (RSI)
  • THAR 64.36
  • SGBX 45.31
  • Support Level
  • THAR $1.30
  • SGBX $0.60
  • Resistance Level
  • THAR $1.46
  • SGBX $0.97
  • Average True Range (ATR)
  • THAR 0.14
  • SGBX 0.12
  • MACD
  • THAR 0.02
  • SGBX -0.03
  • Stochastic Oscillator
  • THAR 96.17
  • SGBX 19.90

About THAR Tharimmune Inc.

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.

About SGBX Safe & Green Holdings Corp.

Safe & Green Holdings Corp is a modular solutions company. The company currently provides modules made out of both code-engineered cargo shipping containers and wood for use as both permanent or temporary structures for residential housing use and commercial use, including for health care facilities. It operates in four segments: construction services; medical; real estate development; and environmental. The company generates the majority of its revenue from the Construction segment includes the company's manufacturing unit SG ECHO and other modules projects.

Share on Social Networks: